Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus

被引:322
作者
Kirou, KA
Lee, C
George, S
Louca, K
Papagiannis, LG
Peterson, MGE
Ly, N
Woodward, RN
Fry, KE
Lau, AYH
Prentice, JG
Wohlgemuth, JG
Crow, MK
机构
[1] Hosp Special Surg, Dept Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[3] Express Diagnost Inc, San Francisco, CA USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 12期
关键词
D O I
10.1002/art.20798
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To study the contribution of interferon-alpha (IFNalpha) and IFNgamma to the IFN gene expression signature that has been observed in microarray screens of peripheral blood mononuclear cells (PBMCs) from patients with systemic lupus erythematosus (SLE). Methods. Quantitative real-time polymerase chain reaction analysis of healthy control PBMCs was used to determine the relative induction of a panel of IFN-inducible genes (IFIGs) by IFNalpha and IFNgamma. PBMCs from 77 SLE patients were compared with those from 22 disease controls and 28 healthy donors for expression of IFIGs. Results. Expression of IFNalpha-inducible genes was significantly higher in SLE PBMCs than in those from disease controls or healthy donors. The level of expression of all IFIGs in PBMCs from SLE patients with IFNalpha pathway activation correlated highly with the inherent responsiveness of those genes to IFNalpha, suggesting coordinate activation of that cytokine pathway. Expression of genes preferentially induced by IFNgamma was not significantly increased in SLE PBMCs compared with control PBMCs. IFNalpha-regulated gene-inducing activity was detected in some SLE plasma samples. Conclusion. The coordinate activation of IFNalpha-induced genes is a characteristic of PBMCs from many SLE patients, supporting the hypothesis that IFNa is the predominant stimulus for IFIG expression in lupus.
引用
收藏
页码:3958 / 3967
页数:10
相关论文
共 50 条
  • [21] Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
    Jego, G
    Palucka, AK
    Blanck, JP
    Chalouni, C
    Pascual, V
    Banchereau, J
    [J]. IMMUNITY, 2003, 19 (02) : 225 - 234
  • [22] Links between type I interferons and the genetic basis of disease in mouse lupus
    Jorgensen, TN
    Gubbels, MR
    Kotzin, BL
    [J]. AUTOIMMUNITY, 2003, 36 (08) : 491 - 502
  • [23] Induction of Fas ligand-mediated apoptosis by interferon-α
    Kirou, KA
    Vakkalanka, RK
    Butler, MJ
    Crow, MK
    [J]. CLINICAL IMMUNOLOGY, 2000, 95 (03) : 218 - 226
  • [24] Kirou KA, 2004, METH MOLEC MED, V102, P129
  • [25] Treatment of murine lupus with cDNA encoding IFN-γR/Fc
    Lawson, BR
    Prud'homme, GJ
    Chang, YG
    Gardner, HA
    Kuan, J
    Kono, DH
    Theofilopoulos, AN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) : 207 - 215
  • [26] Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo
    Le Bon, A
    Schiavoni, G
    D'Agostino, G
    Gresser, I
    Belardelli, F
    Tough, DF
    [J]. IMMUNITY, 2001, 14 (04) : 461 - 470
  • [27] Type I interferons keep activated T cells alive
    Marrack, P
    Kappler, J
    Mitchell, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03) : 521 - 529
  • [28] Type I interferons produced by dendritic cells promote their phenotypic and functional activation
    Montoya, M
    Schiavoni, G
    Mattei, F
    Gresser, I
    Belardelli, F
    Borrow, P
    Tough, DF
    [J]. BLOOD, 2002, 99 (09) : 3263 - 3271
  • [29] Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection
    Nguyen, KB
    Watford, WT
    Salomon, R
    Hofmann, SR
    Pien, GC
    Morinobu, A
    Gadina, M
    O'Shea, JJ
    Biron, CA
    [J]. SCIENCE, 2002, 297 (5589) : 2063 - 2066
  • [30] Nicoletti F, 2000, EUR J IMMUNOL, V30, P438